The liver and the bile ducts: Is it risky to prescribe paracetamol in patients affected with acute or chronic liver diseases?;Y a t-il un risque à prescrire du paracétamol chez des malades atteints d'hépatopathies aiguës ou chroniques?

Gastroenterologie Clinique et Biologique

Volumn 30, Issue 5, 2006, Pages 753-755

  Larrey, Dominique ^a  

^a HÔPITAL SAINT ELOI   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPYRETIC AGENT; GLUTATHIONE; PARACETAMOL;

ACUTE DISEASE; BILE DUCT; BILE DUCT DISEASE; CHRONIC LIVER DISEASE; DRUG DOSE REGIMEN; DRUG FATALITY; DRUG INDICATION; DRUG METABOLISM; DRUG SAFETY; EDITORIAL; HUMAN; LIVER; LIVER DISEASE; LIVER METABOLISM; LIVER TOXICITY; LIVER TRANSPLANTATION; PRESCRIPTION;

EID: 33745500655     PISSN: 03998320     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0399-8320(06)73309-7     Document Type: Editorial

References (24)

1. Rumack BH. Acetaminophen hepatotoxicity: the first 35 years. J Toxicol Clin Toxicol 2002;40:3-20.
2. Kaplowitz N. Acetaminophen hepatoxicity: What do we know, what don't we know, and what do we do next? Hepatology 2004;40:23-6.
3. Larrey D. Hépatite au paracétamol. In: Queneau P, ed. Stratégies thérapeutiques et arbres décisionnels. Paris: Springier-Verlag, 1990;335-9.
4. Pessayre O, Larrey D, Biour M. Drug-induced Liver injury. In: Bircher J, Benhamou JP, McIntyre N, Rizzetto M. Rodés J, eds. Textbook of Clinical Hepatology. 2nd ed, Vol. 2. Oxford: Oxford University Press, 1999;1261-31.
5. nd ed. Philadelphia, Baltimore, New york, London: Lippincott Williams and Wilkins, 1999.
6. Ostapowicz G, Fontana RJ, Schiodt SV, Larson A, Davern TJ, Han SH, et al. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med 2002;137:947-54.
7. Lee WM. Acetaminophen and the US acute liver failure study group: lowering the risks of hepatic failure. Hepatology 2004;40:6-9.
8. Rumack BH. Acetaminopen misconceptions. Hepatology 2004;40:10-5.
9. Nelson SD, Bruschi SA. Mechnisms of acetaminophen-induced liver disease. In: Kaplowitz N, De Leve L, eds. Drug-induced Liver Disease. New York:Marcel Dekker Inc, 2002;287-325.
10. Louvet A, Boitard J, Dharancy S, Duriez A, Deltenre P, Paris JC, et al. La mésaventure du paracétamol chez le buveur excessif. Gastroenterol Clin biol 2006.
11. Larrey D. Epidemiology and individual susceptibility to adverse drug reactions affecting the liver. Sem Liv Dis 2002;22:145-55.
12. Larrey D, Letteron P, Foliot A, Descatoire V, Degott C, Genève J, et al. Effects of pregnancy on the toxicity and metabolism of acetaminophen in mice. J Pharmacol Exp Ther 1986;237:283-91.
13. Yaghi C, Honein K, Boujaoude J, Slim R, Moucari R, Sayegh R. Influence of acetaminophen at therapeutic doses on surrogate markers of severity of acute viral hepatitis. Gastroenterol Clin Biol 2006.
14. Seeff LB, Cuccherini BA, Zimmerman HJ, Adler E, Benjamin SB. Acetaminophen hepatotoxicity in alcoholics: a therapeutic misadventure. Ann Intern Med 1986;104:399-404.
15. Zimmermann HJ, Maddrey WC. Acetaminophen (paracetamol) hepatotoxicity with regular intake of alcohols: analysis of instances of therapeutic misadventure. Hepatology 1995;22:767-73.
16. Schmidt LE, Dalhoff K, Poulsen HE. Acute versus chronic alcohol consumption in acetaminophen-induced hepatotoxicity. Hepatology 2002;35:876-82.
17. Nelson SD. Molecular mechanisms of the hepatotoxicity caused by acetaminophen. Semin Liver Dis 1990;10:267-78.
18. Prescott LF. Paracetamol, alcohol, and the liver. Br J Clin Pharmacol 2000;49:291-301.
19. Schmidt LE, Dalhoff K, Poulsen HE. Acute versus chronic alcohol consumption in acetaminophen-induced hepatotoxicity. Hepatology 2002;35:876-82.
20. Schiodt FV, Lee WM, Bondesen S, Ott P, Christensen E. Influence of acute and chronic alcohol intake on the clinical course and outcome in acetaminophen overdose. Aliment Pharmacol Ther 2002;16:707-15.
21. Rezende G, Roque-Afonso AM, Samuel D, Gigou M, Nicand E, Ferre V, et al. Viral and clinical factors associated with the fulminant course of hepatitis A infection. Hepatology 2003;38:613-18.
22. Prandota J. Important role of prodromal viral infections responsible for inhibition of xenobiotic metabolising enzymes in the patho-mechanism of idiopathic Reye's syndrome, Stevens-Johnson syndrome, autoimmune hepatitis, and hepatotoxicity of the therapeutic doses of acetaminophen used in genetically predisposed persons. Am J Ther 2002;9:149-56.
23. Sklar GE, Subramaniam M. Acetylcysteine treatment for non-acetaminophen-induced acute liver failure. Ann Pharmacother 2004;38:498-500.
24. Larrey D, Pageaux GP. Prescribing drugs in liver disease. In: McIntyre N, Benhamou JP, Bircher J, Rizzetto M, Rodez J, eds. Oxford Textbook of Hepatology. Oxford, New York: Oxford University Press (sous presse).